A detailed history of Jefferies Group LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 3,122 shares of CRL stock, worth $611,193. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,122
Holding current value
$611,193
% of portfolio
0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Sep 21, 2023

SELL
$182.44 - $250.54 $2.22 Million - $3.05 Million
-12,176 Reduced 79.59%
3,122 $614,000
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $661,527 - $908,458
3,626 New
3,626 $617,000
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $5.7 Million - $7.01 Million
-15,298 Closed
0 $0
Q2 2021

Sep 21, 2023

SELL
$294.17 - $371.65 $6.77 Million - $8.55 Million
-23,004 Reduced 60.06%
15,298 $5.66 Million
Q2 2021

Aug 16, 2021

SELL
$294.17 - $371.65 $6.77 Million - $8.55 Million
-23,004 Reduced 60.06%
15,298 $5.66 Million
Q1 2021

Sep 21, 2023

BUY
$249.67 - $299.48 $6.8 Million - $8.15 Million
27,222 Added 245.69%
38,302 $11.1 Million
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $6.8 Million - $8.15 Million
27,222 Added 245.69%
38,302 $11.1 Million
Q4 2020

Sep 21, 2023

BUY
$222.0 - $252.62 $1.65 Million - $1.88 Million
7,454 Added 205.57%
11,080 $2.77 Million
Q4 2020

Feb 16, 2021

BUY
$222.0 - $252.62 $1.35 Million - $1.54 Million
6,080 Added 121.6%
11,080 $2.77 Million
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $858,839 - $1.11 Million
-4,892 Reduced 49.45%
5,000 $1.13 Million
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $1.18 Million - $1.88 Million
9,892 New
9,892 $1.73 Million
Q2 2019

Aug 14, 2019

SELL
$123.4 - $148.55 $754,097 - $907,789
-6,111 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$104.82 - $146.73 $586,992 - $821,688
-5,600 Reduced 47.82%
6,111 $888,000
Q4 2018

Feb 14, 2019

BUY
$105.09 - $137.23 $714,506 - $933,026
6,799 Added 138.42%
11,711 $1.33 Million
Q3 2018

Nov 14, 2018

BUY
$112.11 - $134.54 $142,491 - $171,000
1,271 Added 34.91%
4,912 $661,000
Q2 2018

Aug 14, 2018

BUY
$102.37 - $117.25 $372,729 - $426,907
3,641 New
3,641 $409,000
Q1 2018

May 15, 2018

SELL
$98.19 - $115.2 $853,958 - $1 Million
-8,697 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$100.43 - $118.09 $648,677 - $762,743
-6,459 Reduced 42.62%
8,697 $952,000
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $1.47 Million - $1.66 Million
15,156
15,156 $1.64 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.